Christopher S. Seet

2.4k total citations · 1 hit paper
35 papers, 899 citations indexed

About

Christopher S. Seet is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Christopher S. Seet has authored 35 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 15 papers in Hematology. Recurrent topics in Christopher S. Seet's work include Multiple Myeloma Research and Treatments (10 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (7 papers). Christopher S. Seet is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (7 papers). Christopher S. Seet collaborates with scholars based in United States, Canada and Switzerland. Christopher S. Seet's co-authors include Gay M. Crooks, Barbara L. Kee, Yuhua Zhu, David Casero, Amélie Montel‐Hagen, Suwen Li, Brent Chick, Chongbin He, Jessica Scholes and Annie Luong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Christopher S. Seet

29 papers receiving 890 citations

Hit Papers

Allogeneic CD33-directed CAR-NKT cells for the treatment ... 2025 2026 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher S. Seet United States 14 438 407 371 186 97 35 899
Mobin Karimi United States 11 291 0.7× 524 1.3× 414 1.1× 198 1.1× 46 0.5× 32 927
Arnika Kathleen Wagner Sweden 13 239 0.5× 337 0.8× 236 0.6× 122 0.7× 62 0.6× 43 688
Sanfang Tu China 16 297 0.7× 201 0.5× 582 1.6× 166 0.9× 57 0.6× 52 858
Tatsunori Goto Japan 14 216 0.5× 240 0.6× 435 1.2× 152 0.8× 38 0.4× 48 723
Felix S. Lichtenegger Germany 18 428 1.0× 698 1.7× 684 1.8× 440 2.4× 48 0.5× 35 1.3k
Nan Ring United States 7 258 0.6× 782 1.9× 464 1.3× 58 0.3× 54 0.6× 12 1.1k
Jayakumar Vadakekolathu United Kingdom 16 263 0.6× 207 0.5× 218 0.6× 170 0.9× 116 1.2× 52 602
Imran G. House Australia 12 306 0.7× 642 1.6× 700 1.9× 54 0.3× 58 0.6× 14 1.1k
Yu Kyeong Hwang South Korea 17 292 0.7× 486 1.2× 427 1.2× 95 0.5× 71 0.7× 31 850
Sunil S. Raikar United States 13 205 0.5× 252 0.6× 405 1.1× 108 0.6× 34 0.4× 37 639

Countries citing papers authored by Christopher S. Seet

Since Specialization
Citations

This map shows the geographic impact of Christopher S. Seet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Seet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Seet more than expected).

Fields of papers citing papers by Christopher S. Seet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Seet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Seet. The network helps show where Christopher S. Seet may publish in the future.

Co-authorship network of co-authors of Christopher S. Seet

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Seet. A scholar is included among the top collaborators of Christopher S. Seet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Seet. Christopher S. Seet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Komarova, Natalia L., Dominik Wodarz, Albert L. Gonzales, et al.. (2025). Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns. Nature Communications. 16(1). 9439–9439.
2.
Li, Yan-Ruide, Ying Fang, Yichen Zhu, et al.. (2025). Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies. Nature Communications. 16(1). 1248–1248. 23 indexed citations breakdown →
3.
Bahlis, Nizar J., Christy Samaras, Donna Reece, et al.. (2024). Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014. Clinical Lymphoma Myeloma & Leukemia. 24(12). 852–862. 2 indexed citations
4.
Bahlis, Nizar J., Christy Samaras, Donna Reece, et al.. (2023). MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study. Clinical Lymphoma Myeloma & Leukemia. 23. S494–S495. 1 indexed citations
5.
Li, Suwen, Amélie Montel‐Hagen, Shawn Lopez, et al.. (2023). Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells. Cell Reports. 42(3). 112241–112241. 14 indexed citations
6.
8.
Li, Yanchun, Christopher S. Seet, Kevin Barton, et al.. (2023). Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia. Stem Cell Reports. 19(1). 100–111. 2 indexed citations
9.
Chang, Patrick, Xuegang Yuan, Steven Tsai, et al.. (2023). Generation of antigen-specific mature T cells from RAG1−/−RAG2−/−B2M−/− stem cells by engineering their microenvironment. Nature Biomedical Engineering. 8(4). 461–478. 6 indexed citations
10.
Bahlis, Nizar J., Gary J. Schiller, Christy Samaras, et al.. (2022). P-232: Adverse event patterns and management with pomalidomide, dexamethasone, and daratumumab in patients with relapsed or refractory multiple myeloma: a safety analysis of the phase 2 MM-014 study. Clinical Lymphoma Myeloma & Leukemia. 22. S162–S163. 1 indexed citations
11.
Zeidan, Amer M., Daniel J. DeAngelo, Jeanne Palmer, et al.. (2022). Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes. Annals of Hematology. 101(3). 557–569. 66 indexed citations
12.
Seet, Christopher S., et al.. (2021). DONOR-TRANSMITTED MELANOMA - THE NEED FOR CONTINUOUSLY UPDATED GUIDELINES. Transplant International. 34. 297–298.
13.
McLaughlin, Jami, Donghui Cheng, Nathanael J. Bangayan, et al.. (2021). Droplet-based mRNA sequencing of fixed and permeabilized cells by CLInt-seq allows for antigen-specific TCR cloning. Proceedings of the National Academy of Sciences. 118(3). 8 indexed citations
14.
Bapat, Aditi, Paul Kang, Christopher S. Seet, et al.. (2018). Myeloid Disease Mutations of Splicing Factor SRSF2 Cause G2-M Arrest and Skewed Differentiation of Human Hematopoietic Stem and Progenitor Cells. Stem Cells. 36(11). 1663–1675. 20 indexed citations
16.
Seet, Christopher S., Chongbin He, Michael T. Bethune, et al.. (2017). Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nature Methods. 14(5). 521–530. 162 indexed citations
17.
Berent-Maoz, Beata, Encarnacion Montecino‐Rodriguez, Michael P. Fice, et al.. (2015). The Expansion of Thymopoiesis in Neonatal Mice Is Dependent on Expression of High Mobility Group A 2 Protein (Hmga2). PLoS ONE. 10(5). e0125414–e0125414. 4 indexed citations
18.
Casero, David, Salemiz Sandoval, Christopher S. Seet, et al.. (2015). Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages. Nature Immunology. 16(12). 1282–1291. 141 indexed citations
19.
Seet, Christopher S., Clare Sun, Jing Li, et al.. (2013). p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL‐leukemia. Molecular Oncology. 7(6). 1069–1082. 17 indexed citations
20.
Seet, Christopher S., et al.. (2004). Early B Cell Factor Promotes B Lymphopoiesis with Reduced Interleukin 7 Responsiveness in the Absence of E2A. The Journal of Experimental Medicine. 199(12). 1689–1700. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026